Clinical Trial Update: Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19

View source ↗

Summary

A completed clinical trial evaluating ivermectin, aspirin, dexamethasone, and enoxaparin for severe COVID-19-related respiratory conditions with posted results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syndrome
• Ventilation Pneumonitis

Drugs mentioned

• Aspirin (Aspirin)
• DEXAMETHASONE (Dexamethasone)
• Enoxaparin (enoxaparin sodium)
• IVERMECTIN (Ivermectin)

Snippet

Sponsor: Eurnekian Public Hospital | Conditions: Severe Acute Respiratory Syndrome, Ventilation Pneumonitis | Status: COMPLETED | Results posted: 2020-10-19